Bielsa I

Language: Spanish
References: 14
Page: 51-53
PDF size: 104.39 Kb.

Text Extraction

No abstract

REFERENCES

1. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971-82.

2. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.

3. Hill CL, Zhang Y, Sigurgeirsson B, Pukkale E, Mellemkjaer L, Airio A y cols. Frequency of specific cancer types in dermatomyositis and polymiositis: a population-based study. Lancet 2001;357:96-100.

4. Basset-Seguin N, Roujeau JC, Gherardi R, Guillaume JC, Revuz J, Touraine R. Prognosis factors and predictive signs of malignancy in adult dermatomyositis. Arch Dermatol 1990;126:633-7.

5. Gallais V, Crickx B, Belaïch S. Facteurs pronostiques et signes prédictifs de cancer au cours de la dermatomyosite de l’adulte. Ann Dermatol Venereol 1996;123:722-6.

6. Burnouf M, Mahé E, Verpillat P, Descamps V, Lebrun-Vignes B, Picard-Dahan C y cols. Les necroses cutanées dans les dermatomyosites de l’adulte sont prédictives de l’association à une néoplasie. Ann Dermatol Venereol 2003;313-6.

7. Grau JM, Miró O, Pedrol E, Casademont J, Masanés F, Herrero C y cols. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J Rheumatol 1996;23:1921-6.

8. Amoura Z, Duhaut P, Huong DL, Wechsler B, Costedoat-Chalumeau N, Francès C y cols. Tumor antigen markers for the detection of solid cancers in inflammatory myopathies. Cancer Epidemiol Biomarkers Prev 2005;14:1279-82.

9. Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Senécal JL. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine (Baltimore) 2005;84:231-49.

10. Targoff IN, Mamyrova G, Trieu EP, Perurena O, Koneru B, O’Hanlon TP y cols. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 2006;54:3682-9.

11. Kaji K, Fujimoto M, Hasegawa M, Kondo M, Saito Y, Komura K y cols. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy. Rheumatology (Oxford) 2007;46:25-8.

12. Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 2007;66:1345-9.

13. Sparsa A, Liozon E, Herrmann F, Ly K, Lebrun V, Soria P y cols. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 2002;138:885-90.

14. Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006;54:597-613.